Groups funded by Charles and David Koch have launched ad campaigns aimed at urging Congress to pass legislation that would make it easier for terminally ill patients to try experimental treatments. The bill passed the Senate unanimously, but FDA Commissioner Scott Gottlieb told the House in October (archive) that the FDA already approves 99% of requests for expanded access/compassionate use, and that the primary roadblock is not the FDA, but drug supply constraints. He said that pharmaceutical companies do not continuously manufacture a drug undergoing clinical trials, but instead produce "discontinuous batches":
Several deep-pocketed political advocacy groups founded by Charles and David Koch are ramping up their advocacy before Congress on a niche issue: access to experimental drugs.
On Monday, several Koch-backed groups, including Freedom Partners and Americans for Prosperity, launched an ad campaign urging Congress to pass so-called "right-to-try" legislation, which aims to help terminally ill patients access experimental treatments that haven't yet been approved by the Food and Drug Administration. The Senate unanimously passed a right-to-try bill from Sen. Ron Johnson (R-Wis.) last August, but it has since stalled in the House. Supporters, including lawmakers on Capitol Hill and other off-the-Hill advocates, are focusing their efforts this month on the Energy and Commerce Committee, which would likely have to clear the legislation before the full House could vote on it.
The new ad campaign — also sponsored by Generation Opportunity and The LIBRE Initiative — directly addresses Congress, saying at the end of one commercial, "Congress, give patients a chance. Pass right to try." In addition to a series of digital ads focused on D.C. and key congressional districts, the campaign will include lobbying efforts by the groups, according to a press release. In a letter sent Monday to Committee Chairman Greg Walden (R-Ore.), executives wrote, "We strongly urge your committee to act expeditiously to approve Right to Try legislation and send the bill to the House Floor for a full vote."
Johnson told STAT he's doing everything he can this month to get the legislation passed, and suggested the vice president might become even more engaged. Vice President Mike Pence has supported right-to-try efforts since he signed a similar law as governor of Indiana.
Related: What a Gottlieb-Led FDA Might Mean for the Pharmaceutical Industry
FDA Nominee is a Proponent of "Adaptive Trials"
Texas Sanctions FDA-Unapproved Stem Cell Therapies
University Could Lose Millions From "Unethical" Research Backed by Peter Thiel
"Black Hole" of Accountability for Drug Trials Flouting FDA Oversight?
Drug Approvals Sped Up in 2017
(Score: 2) by c0lo on Wednesday January 10 2018, @02:16PM
I'm sorry to inflict the mystery of my native country on you, magister, I sincerely hope you aren't going to develop an obsession over the matter.
But I promise I'll be the last to deprive you of one of the few mysteries of this world, not circumscribed by The Truth nor let aside of it. A full life need them as much as, some argue, the ἱερόφάνεια.
Ah, a good fellow him. A bit boring if you ask me, way too rationalist, needed lotsa beer to transcend the experience.
Mostly missing the... mmm... how to put it?... "automatisme psychique pur par lequel on se propose d’exprimer ... le fonctionnement réel de la pensée. Dictée de la pensée, en l'absence de tout contrôle exercé par la raison, en dehors de toute préoccupation esthétique ou morale" side of life (yeah, yeah, I know, "El sueño de la razón produce monstruos" - like the pretense of being rational produces something else)
Lacking that, one may make use of creations in the vein of your almost neighbor, Menippus of Gadara. (mmmm... maybe I do need to find some time to read Rabelais and his world [wikipedia.org])
)sorry, badly in need for some sleep. I don't expect the above to be coherent or make sense when read)
https://www.youtube.com/@ProfSteveKeen https://soylentnews.org/~MichaelDavidCrawford